The European market for breast biopsy devices will be worth $118.4 million by 2015, according to a new market research report.
Global Industry Analysts of San Jose, CA, said that market growth will be driven by a rapidly aging population in Europe, enhanced disease screening and detection techniques, and ongoing emphasis on cost-effective and minimally invasive therapies.
On the other hand, the purchase of breast biopsy devices may be hindered by price sensitivity and unclear reimbursement policies. Also, the current global economic weakness has substantially affected the healthcare industry. Cost-conscious consumers may make fewer elective visits to physicians, resulting in lower demand for biopsy products and procedures, the report said.
Related Reading
U.K. cancer survival rates, spending lag Europe, February 18, 2010
European nuke med market could triple, January 25, 2010
European cancer rates declining, report indicates, January 7, 2010
Study: DR catalyst for European x-ray market, January 25, 2008
Study: European CT market growing, September 11, 2007
Copyright © 2010 AuntMinnie.com
